![Microorganisms | Free Full-Text | SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020 Microorganisms | Free Full-Text | SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020](https://www.mdpi.com/microorganisms/microorganisms-09-00850/article_deploy/html/images/microorganisms-09-00850-g004.png)
Microorganisms | Free Full-Text | SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020
![The Exonuclease TREX1 Is in the SET Complex and Acts in Concert with NM23-H1 to Degrade DNA during Granzyme A-Mediated Cell Death: Molecular Cell The Exonuclease TREX1 Is in the SET Complex and Acts in Concert with NM23-H1 to Degrade DNA during Granzyme A-Mediated Cell Death: Molecular Cell](https://www.cell.com/cms/attachment/583076/4400635/gr1.jpg)
The Exonuclease TREX1 Is in the SET Complex and Acts in Concert with NM23-H1 to Degrade DNA during Granzyme A-Mediated Cell Death: Molecular Cell
![Frontiers | IgG Immune Complexes Inhibit Naïve T Cell Proliferation and Suppress Effector Function in Cytotoxic T Cells Frontiers | IgG Immune Complexes Inhibit Naïve T Cell Proliferation and Suppress Effector Function in Cytotoxic T Cells](https://www.frontiersin.org/files/Articles/713704/fimmu-12-713704-HTML-r1/image_m/fimmu-12-713704-g001.jpg)
Frontiers | IgG Immune Complexes Inhibit Naïve T Cell Proliferation and Suppress Effector Function in Cytotoxic T Cells
![Vaccines | Free Full-Text | IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population Vaccines | Free Full-Text | IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population](https://pub.mdpi-res.com/vaccines/vaccines-09-00999/article_deploy/html/images/vaccines-09-00999-g001b.png?1631162858)
Vaccines | Free Full-Text | IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population
![Microorganisms | Free Full-Text | SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020 Microorganisms | Free Full-Text | SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020](https://www.mdpi.com/microorganisms/microorganisms-09-00850/article_deploy/html/images/microorganisms-09-00850-g001-550.jpg)
Microorganisms | Free Full-Text | SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020
![Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic | Science Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic | Science](https://www.science.org/cms/10.1126/science.abe9728/asset/751ba264-469e-4144-b895-27350df5b8af/assets/graphic/371_288_f1.jpeg)
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic | Science
Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants | Journal of the American Chemical Society
![Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines](https://www.mdpi.com/vaccines/vaccines-10-00099/article_deploy/html/images/vaccines-10-00099-g010.png)
Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines
![Maternal brain reactive antibodies profile in autism spectrum disorder: an update | Translational Psychiatry Maternal brain reactive antibodies profile in autism spectrum disorder: an update | Translational Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41398-023-02335-3/MediaObjects/41398_2023_2335_Fig1_HTML.png)
Maternal brain reactive antibodies profile in autism spectrum disorder: an update | Translational Psychiatry
![Vaccines | Free Full-Text | IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population Vaccines | Free Full-Text | IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population](https://www.mdpi.com/vaccines/vaccines-09-00999/article_deploy/html/images/vaccines-09-00999-g001a.png)
Vaccines | Free Full-Text | IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population
![Current Oncology | Free Full-Text | A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency Current Oncology | Free Full-Text | A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency](https://pub.mdpi-res.com/curroncol/curroncol-30-00022/article_deploy/html/images/curroncol-30-00022-g001.png?1671951236)
Current Oncology | Free Full-Text | A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
![SciELO - Brasil - Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according SciELO - Brasil - Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according](https://minio.scielo.br/documentstore/1678-4774/yLGR3jGqYxbmLFyjX6X6vzk/903d16d2914f825ebadff2b7ecdcef6a51b4b870.png)
SciELO - Brasil - Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according
![Frontiers | Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases Frontiers | Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases](https://www.frontiersin.org/files/Articles/696003/fimmu-12-696003-HTML-r1/image_m/fimmu-12-696003-g001.jpg)
Frontiers | Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases
![SciELO - Brasil - Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according SciELO - Brasil - Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according](https://minio.scielo.br/documentstore/1678-4774/yLGR3jGqYxbmLFyjX6X6vzk/8237c3239867af75c7ae2e6b142d386e3aae6f15.png)
SciELO - Brasil - Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according
![Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines](https://pub.mdpi-res.com/vaccines/vaccines-10-00099/article_deploy/html/images/vaccines-10-00099-g014.png?1641807032)